Advertisement
Screener

Siga Technologies INC (SIGA) Cash and Cash Equivalents

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Cash and Cash Equivalents

Siga Technologies INC (SIGA) had Cash and Cash Equivalents of $117.58 million as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06

  • 2026-06-30: Cash and Cash Equivalents, at Carrying Value $117.58M.
  • 2026-03-31: Cash and Cash Equivalents, at Carrying Value $145.56M.
  • 2025-12-31: Cash and Cash Equivalents, at Carrying Value $154.97M.
  • 2025-09-30: Cash and Cash Equivalents, at Carrying Value $171.96M.
Period endCash and Cash Equivalents, at Carrying ValueCash and Cash Equivalents, at Carrying Value as first filed
2026-06-30$117.58M
10-Q · filed 2026-08-06
2026-03-31$145.56M
10-Q · filed 2026-05-07
2025-12-31$154.97M
10-Q · filed 2026-08-06
2025-09-30$171.96M
10-Q · filed 2025-11-06
2025-06-30$182.46M
10-Q · filed 2025-08-05
2025-03-31$162.27M
10-Q · filed 2025-05-08
2024-12-31$155.40M
10-K · filed 2026-03-10
2024-09-30$99.27M
10-Q · filed 2024-11-07
2024-06-30$106.95M
10-Q · filed 2024-08-01
2024-03-31$143.87M
10-Q · filed 2024-05-07
2023-12-31$150.15M
10-K · filed 2025-03-11
2023-09-30$71.11M
10-Q · filed 2023-11-07
2023-06-30$76.21M
10-Q · filed 2023-08-08
2023-03-31$115.68M
10-Q · filed 2023-05-04
2022-12-31$98.79M
10-K · filed 2024-03-12
2022-09-30$109.75M
10-Q · filed 2022-11-03
2022-06-30$114.53M
10-Q · filed 2022-08-04
2022-03-31$153.26M
10-Q · filed 2022-05-05
2021-12-31$103.14M
10-K · filed 2023-03-02
2021-09-30$92.82M
10-Q · filed 2021-11-04
2021-06-30$98.49M
10-Q · filed 2021-08-05
2021-03-31$106.53M
10-Q · filed 2021-05-06
2020-12-31$117.89M
10-K · filed 2022-03-03
2020-09-30$78.66M
10-Q · filed 2020-11-05
2020-06-30$53.07M
10-Q · filed 2020-08-06
2020-03-31$77.38M
10-Q · filed 2020-05-06
2019-12-31$65.25M
10-K · filed 2023-03-02
2019-09-30$78.10M
10-Q · filed 2020-11-05
2019-06-30$100.26M
10-Q · filed 2020-08-06
2019-03-31$102.09M
10-Q · filed 2020-05-06
2018-12-31$100.65M
10-K · filed 2022-03-03
2018-09-30$103.99M
10-Q · filed 2019-11-05
2018-06-30$10.58M
10-Q · filed 2019-08-06
2018-03-31$13.93M
10-Q · filed 2019-05-02
2017-12-31$19.86M
10-K · filed 2021-03-04
2017-09-30$25.80M
10-Q · filed 2018-11-06
2017-06-30$30.87M
10-Q · filed 2018-08-07
$30.87M
10-Q · filed 2017-08-03
2017-03-31$30.10M
10-Q · filed 2018-05-04
2016-12-31$28.70M
10-K · filed 2020-03-05
2016-09-30$20.49M
10-Q · filed 2017-11-07
2016-06-30$78.02M
10-Q · filed 2017-08-03
2016-03-31$104.06M
10-Q · filed 2017-05-04
2015-12-31$112.71M
10-K · filed 2019-03-06
2015-09-30$129.29M
10-Q · filed 2016-11-02
2015-06-30$115.66M
10-Q · filed 2016-08-08
2015-03-31$95.55M
10-Q · filed 2016-05-04
2014-12-31$99.71M
10-K · filed 2018-03-06
2014-09-30$104.68M
10-Q · filed 2015-10-27
2014-06-30$99.03M
10-Q · filed 2015-08-04
2014-03-31$107.07M
10-Q · filed 2015-05-06
2013-12-31$91.31M
10-K · filed 2017-03-07
2013-09-30$105.19M
10-Q · filed 2014-11-04
2013-06-30$32.96M
10-Q · filed 2014-07-31
2013-03-31$24.69M
10-Q · filed 2014-05-01
2012-12-31$32.02M
10-K · filed 2016-03-04
2012-09-30$22.67M
10-Q · filed 2013-11-06
2012-06-30$34.93M
10-Q · filed 2013-08-05
2012-03-31$42.59M
10-Q · filed 2013-05-15
2011-12-31$49.26M
10-K · filed 2015-03-06
2011-09-30$12.41M
10-Q · filed 2012-11-05
2011-06-30$5.00M
10-Q · filed 2012-08-06
2011-03-31$3.84M
10-Q · filed 2012-05-07
2010-12-31$6.33M
10-K/A · filed 2013-05-15
2010-09-30$5.71M
10-Q · filed 2011-11-08
2010-06-30$6.54M
10-Q · filed 2011-08-01
2009-12-31$6.33M
10-K · filed 2014-03-10
$14.50M
10-Q · filed 2011-08-01
2008-12-31$2.32M
10-K · filed 2012-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B